Cargando…

Dose- and time-response for breast cancer risk after radiation therapy for benign breast disease.

Exposure of the breast to ionising radiation increases the risk of breast cancer, especially among young women. However, some issues remain controversial, for instance the shape of the dose-response curve and the expression of time-related excess. The main purpose of this report was to examine the d...

Descripción completa

Detalles Bibliográficos
Autores principales: Mattsson, A., Rudén, B. I., Palmgren, J., Rutqvist, L. E.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1995
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2034025/
https://www.ncbi.nlm.nih.gov/pubmed/7547222
_version_ 1782136966470434816
author Mattsson, A.
Rudén, B. I.
Palmgren, J.
Rutqvist, L. E.
author_facet Mattsson, A.
Rudén, B. I.
Palmgren, J.
Rutqvist, L. E.
author_sort Mattsson, A.
collection PubMed
description Exposure of the breast to ionising radiation increases the risk of breast cancer, especially among young women. However, some issues remain controversial, for instance the shape of the dose-response curve and the expression of time-related excess. The main purpose of this report was to examine the dose-response curves for radiation-induced breast cancer formulated according to radiobiological target theories. Another purpose was to analyse the time-related excess of breast cancer risk after exposure when dose and age at first exposure were held constant. Breast cancer incidence was analysed in a cohort of 3090 women diagnosed with benign breast disease during 1925-61 (median age 37 years). Of these, 1216 were treated with radiation therapy. The dose range was 0-50 Gy (mean 5.8 Gy). The incidence rate as function of dose was analysed using a linear-quadratic Poisson regression model. Cell-killing effects and other modifying effects were incorporated through additional log-linear terms. Additive and multiplicative models were compared in estimating the time-related excess. The analysis, which was based on 278 breast cancer cases, showed a linear dose-response relationship at low to medium dose levels with a cell-killing effect of 5% Gy-1 (95% confidence interval 2-9%). For a given absorbed dose and age at first exposure the time-related excess was proportional to the background rates with a suggestion that the excess remains throughout life.
format Text
id pubmed-2034025
institution National Center for Biotechnology Information
language English
publishDate 1995
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-20340252009-09-10 Dose- and time-response for breast cancer risk after radiation therapy for benign breast disease. Mattsson, A. Rudén, B. I. Palmgren, J. Rutqvist, L. E. Br J Cancer Research Article Exposure of the breast to ionising radiation increases the risk of breast cancer, especially among young women. However, some issues remain controversial, for instance the shape of the dose-response curve and the expression of time-related excess. The main purpose of this report was to examine the dose-response curves for radiation-induced breast cancer formulated according to radiobiological target theories. Another purpose was to analyse the time-related excess of breast cancer risk after exposure when dose and age at first exposure were held constant. Breast cancer incidence was analysed in a cohort of 3090 women diagnosed with benign breast disease during 1925-61 (median age 37 years). Of these, 1216 were treated with radiation therapy. The dose range was 0-50 Gy (mean 5.8 Gy). The incidence rate as function of dose was analysed using a linear-quadratic Poisson regression model. Cell-killing effects and other modifying effects were incorporated through additional log-linear terms. Additive and multiplicative models were compared in estimating the time-related excess. The analysis, which was based on 278 breast cancer cases, showed a linear dose-response relationship at low to medium dose levels with a cell-killing effect of 5% Gy-1 (95% confidence interval 2-9%). For a given absorbed dose and age at first exposure the time-related excess was proportional to the background rates with a suggestion that the excess remains throughout life. Nature Publishing Group 1995-10 /pmc/articles/PMC2034025/ /pubmed/7547222 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Research Article
Mattsson, A.
Rudén, B. I.
Palmgren, J.
Rutqvist, L. E.
Dose- and time-response for breast cancer risk after radiation therapy for benign breast disease.
title Dose- and time-response for breast cancer risk after radiation therapy for benign breast disease.
title_full Dose- and time-response for breast cancer risk after radiation therapy for benign breast disease.
title_fullStr Dose- and time-response for breast cancer risk after radiation therapy for benign breast disease.
title_full_unstemmed Dose- and time-response for breast cancer risk after radiation therapy for benign breast disease.
title_short Dose- and time-response for breast cancer risk after radiation therapy for benign breast disease.
title_sort dose- and time-response for breast cancer risk after radiation therapy for benign breast disease.
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2034025/
https://www.ncbi.nlm.nih.gov/pubmed/7547222
work_keys_str_mv AT mattssona doseandtimeresponseforbreastcancerriskafterradiationtherapyforbenignbreastdisease
AT rudenbi doseandtimeresponseforbreastcancerriskafterradiationtherapyforbenignbreastdisease
AT palmgrenj doseandtimeresponseforbreastcancerriskafterradiationtherapyforbenignbreastdisease
AT rutqvistle doseandtimeresponseforbreastcancerriskafterradiationtherapyforbenignbreastdisease